Janet Hanley checks a spreadsheet across nearly 450,000 patient records in Scotland, and the numbers tell a story that could reshape how the world manages one of its deadliest conditions. Her research team at Edinburgh Napier University and the University of Edinburgh has just published evidence that patients using home blood pressure telemonitoring—a system that lets people measure their own readings and send them directly to their doctors—cut their risk of hospitalization and death from heart attack and stroke far more effectively than standard care alone.
High blood pressure silently damages millions. It claims an estimated 7.5 million lives annually, yet it rarely announces itself with symptoms, which is why patients need constant monitoring. Doctors have long known that lifestyle changes and medicines help control it, but the real-world impact of letting patients monitor themselves at home, in the comfort of their own spaces, has been harder to measure. Previous studies showed telemonitoring improved blood pressure control, yet long-term outcomes—the strokes, the heart attacks, the deaths prevented—remained uncertain until now.
Between 2019 and 2022, Hanley's team watched what happened when 9,500 Scottish patients used Connect Me BP, a telemonitoring service that sends digital reminders when it's time for a reading. The remaining patients in the study received standard care from their local GP. Within three months, the telemonitoring group had lower blood pressure readings. But here's what mattered most: they also experienced significantly fewer hospitalizations and deaths from cardiovascular events compared to the standard care group. Those benefits held steady for over a year.
The findings, published in the European Heart Journal–Digital Health, are particularly striking because they came from real-world data—not a tightly controlled lab setting. Brian McKinstry, from the University of Edinburgh's Usher Institute, emphasized the study's strength: "This study provides the strongest evidence to date that telemonitoring not only reduces blood pressure but strokes and heart attacks too." The research team was careful to account for differences that might skew results—younger patients, those on fewer medications, those from less deprived areas—yet the benefits held.
Scotland has already moved boldly on this. With 130,000 people having used Connect Me BP for both diagnosis and ongoing blood pressure control, the nation is now leading the world in deploying this technology at scale. It's the kind of innovation that eases pressure on health systems stretched thin, while giving ordinary people a tool that's "easy and convenient to use," as Hanley notes.
Yet questions linger. The researchers acknowledge that unmeasured differences between those who adopted telemonitoring and those who didn't might have played a role. They're calling for further research to explore whether the benefits extend to higher-risk groups and more diverse populations—especially people from socioeconomically deprived areas, who face the greatest burden from these diseases. "It is important that we enable people from the most socioeconomically deprived parts of the country who are most at risk of these conditions to benefit from it," McKinstry said.
What emerges is a glimpse of healthcare's future: technology that empowers rather than replaces, that turns patients into active monitors of their own health, and that, judging by the numbers, actually saves lives.